Global Diabetic Foot Ulcers Therapeutics Market 2020-2024

Global Diabetic Foot Ulcers Therapeutics Market 2020-2024

Technavio has been monitoring the diabetic foot ulcers therapeutics market and it is poised to grow by $ 986.41 mn during 2020-2024 progressing at a CAGR of 9% during the forecast period. Our reports on diabetic foot ulcers therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the strong drug development pipeline and rising number of diabetes awareness programs. In addition, strong drug development pipeline is anticipated to boost the growth of the market as well.

The diabetic foot ulcers therapeutics market analysis includes product segment and geographical landscapes

Technavio's diabetic foot ulcers therapeutics market is segmented as below:

By Product

  • Ischemic and neuro-ischemic ulcer therapeutics
  • Neuropathic ulcer therapeutics
By Geographical Landscapes
  • North America
  • Europe
  • Asia
  • ROW
This study identifies the Increasing incidence of diabetic foot ulcers as one of the prime reasons driving the diabetic foot ulcers therapeutics market growth during the next few years.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our diabetic foot ulcers therapeutics market covers the following areas:
  • Diabetic foot ulcers therapeutics market sizing
  • Diabetic foot ulcers therapeutics market forecast
  • Diabetic foot ulcers therapeutics market industry analysis
Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading diabetic foot ulcers therapeutics market vendors that include 3M Co., Baxter International Inc., ConvaTec Inc., Dr. Reddys Laboratories Ltd., Fresenius SE & Co. KGaA, GlaxoSmithKline Plc, Merck & Co. Inc., Mylan NV, Pfizer Inc., and Smith & Nephew Plc. Also, the diabetic foot ulcers therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.


  • Executive Summary
  • Market Landscape
    • Market ecosystem
      • Table Parent market
    • Market characteristics
      • Table Market characteristics
    • Value chain analysis
      • Table Value chain analysis- Pharmaceuticals
      • R&D and drug discovery:
      • Integration and product development:
      • Manufacturing:
      • Outbound logistics:
      • Marketing and sales:
      • Support services:
  • Market Sizing
    • Market definition
      • Table Offerings of vendors included in the market definition
    • Market segment analysis
      • Table Market segments
    • Market size 2019
    • Market outlook: Forecast for 2019 - 2024
      • Table Global - Market size and forecast 2019 - 2024 ($ million)
      • Table Global- Market size and forecast 2019-2024 ($ million), exclusive of COVID-19 impact
      • Table Global market: Year-over-year growth 2019 - 2024 (%)
  • Five Forces Analysis
    • Five forces summary
      • Table Five forces analysis 2019 & 2024
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition - Five forces 2019
  • Market Segmentation by Product
    • Market segments
      • Table Product - Market share 2019-2024 (%)
    • Comparison by Product
      • Table Comparison by Product
    • Ischemic and neuro-ischemic ulcer therapeutics - Market size and forecast 2019-2024
      • Table Ischemic and neuro-ischemic ulcer therapeutics - Market size and forecast 2019-2024 ($ million)
      • Table Ischemic and neuro-ischemic ulcer therapeutics - Market size and forecast 2019-2024 ($million), exclusive of COVID-19 impact
      • Table Ischemic and neuro-ischemic ulcer therapeutics - Year-over-year growth 2019- 2024 (%)
    • Neuropathic ulcer therapeutics - Market size and forecast 2019-2024
      • Table Neuropathic ulcer therapeutics - Market size and forecast 2019-2024 ($ million)
      • Table Neuropathic ulcer therapeutics - Market size and forecast 2019-2024 ($million), exclusive of COVID-19 impact
      • Table Neuropathic ulcer therapeutics - Year-over-year growth 2019-2024 (%)
    • Market opportunity by Product
      • Table Market opportunity by Product
  • Customer landscape
    • Table Customer landscape
  • Geographic Landscape
    • Geographic segmentation
      • Table Market share by geography 2019-2024 (%)
    • Geographic comparison
      • Table Geographic comparison
    • North America - Market size and forecast 2019- 2024
      • Table North America - Market size and forecast 2019-2024 ($ million)
      • Table North America - Market size and forecast 2019-2024 ($million), exclusive of COVID-19 impact
      • Table North America - Year-over-year growth 2019-2024 (%)
    • Europe - Market size and forecast 2019-2024
      • Table Europe - Market size and forecast 2019-2024 ($ million)
      • Table Europe - Market size and forecast 2019-2024 ($million), exclusive of COVID-19 impact
      • Table Europe - Year-over-year growth 2019-2024 (%)
    • Asia - Market size and forecast 2019-2024
      • Table Asia - Market size and forecast 2019-2024 ($ million)
      • Table Asia - Market size and forecast 2019-2024 ($million), exclusive of COVID-19 impact
      • Table Asia - Year-over-year growth 2019-2024 (%)
    • ROW - Market size and forecast 2019-2024
      • Table ROW - Market size and forecast 2019-2024 ($ million)
      • Table ROW - Market size and forecast 2019-2024 ($million), exclusive of COVID-19 impact
      • Table ROW - Year-over-year growth 2019-2024 (%)
    • Key leading countries
      • Table Key leading countries
    • Market opportunity by geography
      • Table Market opportunity by geography ($ million)
  • Drivers, Challenges, and Trends
    • Market drivers
      • Strong drug development pipeline
      • Increasing incidence of diabetic foot ulcers
      • Rising number of diabetes awareness programs
    • Market challenges
      • Impact of complex pathogenesis in clinical trial design
      • High entry barriers
      • Poor wound care management
        • Table Impact of drivers and challenges
    • Market trends
      • Increasing wound healing therapeutics
      • Increased outsourcing of non-core activities
      • Increase in R&D activities
  • Vendor Landscape
    • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
      • Table Industry risks
    • Competitive scenario
  • Vendor Analysis
    • Vendors covered
      • Table Vendors covered
    • Market positioning of vendors
      • Table Market positioning of vendors
    • 3M Co.
      • Table 3M Co. - Overview
      • Table 3M Co. - Business segments
      • Table 3M Co. - Key news
      • Table 3M Co. - Key offerings
      • Table 3M Co. - Segment focus
    • Baxter International Inc.
      • Table Baxter International Inc. - Overview
      • Table Baxter International Inc. - Business segments
      • Table Baxter International Inc. - Key news
      • Table Baxter International Inc. - Key offerings
      • Table Baxter International Inc. - Segment focus
    • ConvaTec Inc.
      • Table ConvaTec Inc. - Overview
      • Table ConvaTec Inc. - Product and service
      • Table ConvaTec Inc. - Key offerings
    • Dr. Reddys Laboratories Ltd.
      • Table Dr. Reddys Laboratories Ltd. - Overview
      • Table Dr. Reddys Laboratories Ltd. - Business segments
      • Table Dr. Reddys Laboratories Ltd. - Key news
      • Table Dr. Reddys Laboratories Ltd. - Key offerings
      • Table Dr. Reddys Laboratories Ltd. - Segment focus
    • Fresenius SE & Co. KGaA
      • Table Fresenius SE & Co. KGaA - Overview
      • Table Fresenius SE & Co. KGaA - Business segments
      • Table Fresenius SE & Co. KGaA - Key news
      • Table Fresenius SE & Co. KGaA - Key offerings
      • Table Fresenius SE & Co. KGaA - Segment focus
    • GlaxoSmithKline Plc
      • Table GlaxoSmithKline Plc - Overview
      • Table GlaxoSmithKline Plc - Business segments
      • Table GlaxoSmithKline Plc - Key news
      • Table GlaxoSmithKline Plc - Key offerings
      • Table GlaxoSmithKline Plc - Segment focus
    • Merck & Co. Inc.
      • Table Merck & Co. Inc. - Overview
      • Table Merck & Co. Inc. - Business segments
      • Table Merck & Co. Inc. - Key news
      • Table Merck & Co. Inc. - Key offerings
      • Table Merck & Co. Inc. - Segment focus
    • Mylan NV
      • Table Mylan NV - Overview
      • Table Mylan NV - Business segments
      • Table Mylan NV - Key news
      • Table Mylan NV - Key offerings
      • Table Mylan NV - Segment focus
    • Pfizer Inc.
      • Table Pfizer Inc. - Overview
      • Table Pfizer Inc. - Business segments
      • Table Pfizer Inc. - Key news
      • Table Pfizer Inc. - Key offerings
      • Table Pfizer Inc. - Segment focus
    • Smith & Nephew Plc
      • Table Smith & Nephew Plc - Overview
      • Table Smith & Nephew Plc - Business segments
      • Table Smith & Nephew Plc - Key news
      • Table Smith & Nephew Plc - Key offerings
      • Table 0lSmith & Nephew Plc - Segment focus
  • Appendix
    • Scope of the report
      • Market definition
      • Objectives
      • Notes and caveats
    • Currency conversion rates for US$
      • Table Currency conversion rates for US$
    • Research methodology
      • Table Research Methodology
      • Table Validation techniques employed for market sizing
      • Table Information sources
    • List of abbreviations
      • Table List of abbreviations

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook